Worldwide registry of heart problems linked to cancer treatment
Collects health data to find risk factors for heart harm in cancer patients.
Key facts
- Who runs it
- The Cleveland Clinic
- Where
- Weston, United StatesSee the site
- Trial code
- Registry title
- Global Cardio Oncology Registry
- Status
- Recruiting
- People taking part
- 5,000 people, planned
- Started
- 1 Jul 2022
- Expected to end
- 1 Jul 2029
- Type of study
- Observational, 3 groups
- Treatments tested
- anonymized data collection during programmed surveillance clinical follow up
- Record updated
- 12 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with breast cancer, blood cancers, or cancer treated with immune checkpoint inhibitors who have a first visit with a heart-and-cancer (cardio-oncology) doctor. It only collects data during usual check-ups.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Breast cancer, Hodgkin's or non-Hodgkin's lymphoma, acute or chronic leukemia, multiple myeloma or AL amyloidosis, or any cancer treated with immune checkpoint inhibitors that needs a heart check.
- Earlier treatment
- For one group: treatment with immune checkpoint inhibitors.
Main reasons for not taking part
- People who already had a cardio-oncology check and follow-up by the trial doctors
- People younger than 18 years
- People unable or unwilling to give consent
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- New cardio-oncology consultation for breast cancer patients, or
- New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or
- New cardio-oncology consultation for acute or chronic leukemia patients, or
- New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or
- New cardio-oncology consultations for immune check-point inhibitors cardiac evaluation
- All patients have to be 18 years old or older
Who cannot take part
- Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators
- Minors less than 18 years old
- Inability or unwillingness to consent to participate
Where in United States
- Cleveland Clinic FloridaWeston, United StatesContact: Diego Sadler, MD FACCTaking people
About the trial
What the trial wants to find out
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.
The 3 groups in the trial
- Breast cancer
Patients with breast cancer who present for initial cardio-oncology consultation. Clinical follow up for 18 months.
Treatment: anonymized data collection during programmed surveillance clinical follow up
- Hematological malignancies
Patients with lymphomas, leukemias, multiple myeloma, and AL amyloidosis who present for initial cardio-oncology consultation. Clinical follow up for 18 months.
Treatment: anonymized data collection during programmed surveillance clinical follow up
- Immune check point inhibitors
Patients with any type of cancer treated with immune check point inhibitors who present for initial cardio-oncology consultation. Clinical follow for 18 months
Treatment: anonymized data collection during programmed surveillance clinical follow up
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Global Cardio Oncology Registry
- Plain-language title
- Worldwide registry of heart problems linked to cancer treatmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 12 May 2026